← Back to Search

Other

surgical stabilization for Multiple Rib Fractures (SSRF Trial)

N/A

Waitlist Available

Led By David Meyers, MD

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months after admission

Awards & highlights

SSRF Trial Summary

This trial will compare the outcomes of two different treatments for adults with rib fractures. One group will receive usual care, while the other group will receive usual care plus early surgical stabilization. The trial will also evaluate how different subgroups of patients respond to the two treatments and what effect multiple rib fractures have on patients' post-discharge health and ability to return to work or usual physical activity.

Eligible Conditions

Multiple Rib Fractures
Traumatic Chest Injury

SSRF Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months after admission

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months after admission

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after admission for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Hospital Length of Stay

Secondary outcome measures

Health Status as Assessed by Index Score on the Euroqol-5D-5L

Health Status as Assessed by Visual Analog Scale (VAS) Score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L)

Health Status as Indicated by Level of Impairment as Assessed by the Euroqol-5D-5L

+15 more

SSRF Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Early surgical stabilizationExperimental Treatment1 Intervention

This arm will include early surgical stabilization (within 72 hours of admission) in addition to the usual care received for patients with multiple rib fractures. Usual care will involve pain management.

Group II: Usual careActive Control1 Intervention

This arm will be usual care only. Usual care will include pain managment.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

surgical stabilization

2020

N/A

~90

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH

99 Previous Clinical Trials

36,216 Total Patients Enrolled

The University of Texas Health Science Center, HoustonLead Sponsor

909 Previous Clinical Trials

323,657 Total Patients Enrolled

National Center for Advancing Translational Sciences (NCATS)NIH

322 Previous Clinical Trials

401,461 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there current opportunities to participate in this experiment?

"Affirmative. Clinicaltrials.gov displays that this trial is recruiting for 150 individuals at one centre, and was initially listed on February 23rd 2020 before being revised March 21st 2022."

Answered by AI

How many participants have been admitted to the experiment thus far?

"Affirmative. Clinicaltrials.gov lists this medical trial as currently recruiting patients, with the original post date of February 23rd 2020 and last updated on March 21st 2022. The study is seeking to enroll 150 participants at one primary site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Surgical Stabilization for Rib Fractures

David E. Meyer, MD, MS, FACS 2020. "Surgical Stabilization for Rib Fractures". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04081233.